Rhino defines H3K9me3-marked piRNA clusters
Rhino defines H3K9me3-marked piRNA clusters |
https://doi.org/10.18632/oncotarget.5178
Bowen Yu,
and Ying Huang
|
20740-20741 |
Mitochondrial transport of protoporphyrinogen IX in erythroid cells
Mitochondrial transport of protoporphyrinogen IX in erythroid cells |
https://doi.org/10.18632/oncotarget.5124
Yvette Y. Yien,
Alessa R. Ringel,
and Barry H. Paw
|
20742-20743 |
Lipid transport and epithelial barrier integrity
Lipid transport and epithelial barrier integrity |
https://doi.org/10.18632/oncotarget.5233
Jill M. Fritz,
Li Yang,
and Timothy E. Weaver
|
20744-20745 |
RB in DNA repair |
https://doi.org/10.18632/oncotarget.5234
Paul H. Huang,
Rebecca Cook,
and Sibylle Mittnacht
|
20746-20747 |
Conversion of the CD8 lineage to CD4 T cells
Conversion of the CD8 lineage to CD4 T cells |
https://doi.org/10.18632/oncotarget.5235
Maria P. Guzman,
and Zhibin Chen
|
20748-20749 |
Hedgehog fuels gut regeneration
Hedgehog fuels gut regeneration |
https://doi.org/10.18632/oncotarget.4929
Aiguo Tian,
and Jin Jiang
|
20750-20751 |
Autophagy restricts HIV-1 infection
Autophagy restricts HIV-1 infection |
https://doi.org/10.18632/oncotarget.5123
Coralie F. Daussy,
Bruno Beaumelle,
and Lucile Espert
|
20752-20753 |
Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity
Mitochondria, calcium, and tumor suppressor Fus1: At the crossroad of cancer, inflammation, and autoimmunity |
https://doi.org/10.18632/oncotarget.4537
Roman Uzhachenko,
Anil Shanker,
Alla V. Ivanova,
and Alla V. Ivanova
|
20754-20772 |
Exercise for the heart: signaling pathways
Exercise for the heart: signaling pathways |
https://doi.org/10.18632/oncotarget.4770
Lichan Tao,
Yihua Bei,
Haifeng Zhang,
Junjie Xiao,
and Xinli Li
|
20773-20784 |
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance
Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance |
https://doi.org/10.18632/oncotarget.4750
Markus Morkel,
Pamela Riemer,
Hendrik Bläker,
and Christine Sers
|
20785-20800 |
Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression
Cyclin-dependent kinase 2 is an ideal target for ovary tumors with elevated cyclin E1 expression |
https://doi.org/10.18632/oncotarget.4600
Liu Yang,
Dongdong Fang,
Huijun Chen,
Yiyu Lu,
Zheng Dong,
Han-Fei Ding,
Qing Jing,
Shi-Bing Su,
and Shuang Huang
|
20801-20812 |
Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A
Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A |
https://doi.org/10.18632/oncotarget.5175
Bi-Hong Xu,
Xiao-Xing Li,
Yang Yang,
Mei-Yin Zhang,
Hui-Lan Rao,
Hui-Yun Wang,
and X.F. Steven Zheng
|
20813-20828 |
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies
A differentially expressed set of microRNAs in cerebro-spinal fluid (CSF) can diagnose CNS malignancies |
https://doi.org/10.18632/oncotarget.4096
Alessandra Drusco,
Arianna Bottoni,
Alessandro Lagana',
Mario Acunzo,
Matteo Fassan,
Luciano Cascione,
Anna Antenucci,
Prasanthi Kumchala,
Caterina Vicentini,
Marina P. Gardinam,
Hansjuerg Alder,
Mariantonia A. Carosi,
Mario Ammirati,
Stefano Gherardi,
Marilena Luscri',
Carmine Carapella,
Nicola Zanesi,
and Carlo M. Croce
|
20829-20839 |
Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy
Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy |
https://doi.org/10.18632/oncotarget.4428
Erika Vacchelli,
Michaela Semeraro,
David P. Enot,
Kariman Chaba,
Vichnou Poirier Colame,
Peggy Dartigues,
Aurelie Perier,
Irene Villa,
Sylvie Rusakiewicz,
Caroline Gronnier,
Diane Goéré,
Christophe Mariette,
Laurence Zitvogel,
and Guido Kroemer
|
20840-20850 |
Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice
Splenocytes derived from young WT mice prevent AD progression in APPswe/PSENldE9 transgenic mice |
https://doi.org/10.18632/oncotarget.4930
Fei Wang,
Xueyan Shen,
Shuping Li,
Long Chen,
Yanru Wang,
Jie Qin,
Guomin Zhou,
Yuwen Peng,
Xiaoyuan Feng,
Ruixi Li,
and Chunmin Liang
|
20851-20862 |
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility
Comprehensive molecular pathology analysis of small bowel adenocarcinoma reveals novel targets with potential for clinical utility |
https://doi.org/10.18632/oncotarget.4576
Muhammad A Alvi,
Darragh G McArt,
Paul Kelly,
Marc-Aurel Fuchs,
Matthew Alderdice,
Clare M McCabe,
Victoria Bingham,
Claire McGready,
Shailesh Tripathi,
Frank Emmert-Streib,
Maurice B Loughrey,
Stephen McQuaid,
Perry Maxwell,
Peter W Hamilton,
Richard Turkington,
Jacqueline A James,
Richard H Wilson,
and Manuel Salto-Tellez
|
20863-20874 |
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption
PRDX6 controls multiple sclerosis by suppressing inflammation and blood brain barrier disruption |
https://doi.org/10.18632/oncotarget.5205
Hyung-Mun Yun,
Kyung-Ran Park,
Eun-Cheol Kim,
and Jin Tae Hong
|
20875-20884 |
Combination genetic signature stratifies lower-grade gliomas better than histological grade
Combination genetic signature stratifies lower-grade gliomas better than histological grade |
https://doi.org/10.18632/oncotarget.4928
Aden Ka-Yin Chan,
Yu Yao,
Zhenyu Zhang,
Zhifeng Shi,
Liang Chen,
Nellie Yuk-Fei Chung,
Joseph Shu-Ming Liu,
Kay Ka-Wai Li,
Danny Tat-Ming Chan,
Wai Sang Poon,
Liangfu Zhou,
and Ho-Keung Ng
|
20885-20901 |
Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells
Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells |
https://doi.org/10.18632/oncotarget.3939
Joao Paulo Oliveira-Costa,
Alex Fiorini de Carvalho,
Giorgia Gobbi da Silveira,
Peter Amaya,
Yongqi Wu,
Kyoung-Joo Jenny Park,
Mabel Pinilla Gigliola,
Maryam Lustberg,
Marcilei Eliza Cavicchioli Buim,
Elisa Napolitano Ferreira,
Luiz Paulo Kowalski,
Jeffrey J. Chalmers,
Fernando Augusto Soares,
Dirce Maria Carraro,
and Alfredo Ribeiro-Silva
|
20902-20920 |
Cenp-E inhibitor GSK923295: Novel synthetic route and use as a tool to generate aneuploidy
Cenp-E inhibitor GSK923295: Novel synthetic route and use as a tool to generate aneuploidy |
https://doi.org/10.18632/oncotarget.4879
Ailsa Bennett,
Beatrice Bechi,
Anthony Tighe,
Sarah Thompson,
David J Procter,
and Stephen S Taylor
|
20921-20932 |
The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis
The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis |
https://doi.org/10.18632/oncotarget.3055
Christophe Chapard,
Daniel Hohl,
and Marcel Huber
|
20933-20945 |
Mechanical phenotype of cancer cells: cell softening and loss of stiffness sensing
Mechanical phenotype of cancer cells: cell softening and loss of stiffness sensing |
https://doi.org/10.18632/oncotarget.4173
Hsi-Hui Lin,
Hsiu-Kuan Lin,
I-Hsuan Lin,
Yu-Wei Chiou,
Horn-Wei Chen,
Ching-Yi Liu,
Hans I-Chen Harn,
Wen-Tai Chiu,
Yang-Kao Wang,
Meng-Ru Shen,
and Ming-Jer Tang
|
20946-20958 |
Virus-Clip: a fast and memory-efficient viral integration site detection tool at single-base resolution with annotation capability
Virus-Clip: a fast and memory-efficient viral integration site detection tool at single-base resolution with annotation capability |
https://doi.org/10.18632/oncotarget.4187
Daniel WH Ho,
Karen MF Sze,
and Irene OL Ng
|
20959-20963 |
Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma
Tensin4 is up-regulated by EGF-induced ERK1/2 activity and promotes cell proliferation and migration in hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.4122
Lo-Kong Chan,
Yung-Tuen Chiu,
Karen Man-Fong Sze,
and Irene Oi-Lin Ng
|
20964-20976 |
TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia
TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.4007
Nan Wang,
Dan Guo,
YangYang Zhao,
ChengYa Dong,
XiaoYan Liu,
BinXia Yang,
ShuWei Wang,
Lin Wang,
QingGuo Liu,
Qian Ren,
YongMin Lin,
and XiaoTong Ma
|
20977-20992 |
Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis
Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis |
https://doi.org/10.18632/oncotarget.3663
Jiguang Ma,
Wanxing Duan,
Suxia Han,
Jianjun Lei,
Qinhong Xu,
Xin Chen,
Zhengdong Jiang,
Ligang Nan,
Jiahui Li,
Ke Chen,
Liang Han,
Zheng Wang,
Xuqi Li,
Erxi Wu,
and Xiongwei Huo
|
20993-21003 |
ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells |
https://doi.org/10.18632/oncotarget.4217
Xiaoye Liu,
Xiaoting Yu,
Jingjing Xie,
Mengna Zhan,
Zhuo Yu,
Li Xie,
Hongxiang Zeng,
Feifei Zhang,
Guoqiang Chen,
Xianghua Yi,
and Junke Zheng
|
21004-21015 |
Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts
Mitochondrial ribosomal protein S18-2 evokes chromosomal instability and transforms primary rat skin fibroblasts |
https://doi.org/10.18632/oncotarget.4123
Suhas D. Darekar,
Muhammad Mushtaq,
Sreeharsha Gurrapu,
Larysa Kovalevska,
Catherine Drummond,
Maria Petruchek,
Luca Tirinato,
Enzo Di Fabrizio,
Ennio Carbone,
and Elena Kashuba
|
21016-21028 |
Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1
Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1 |
https://doi.org/10.18632/oncotarget.3763
Sebastian Krossa,
Anne Dorothée Schmitt,
Kirsten Hattermann,
Jürgen Fritsch,
Axel J. Scheidig,
Hubertus Maximilian Mehdorn,
and Janka Held-Feindt
|
21029-21045 |
MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4
MicroRNA-301a-3p promotes pancreatic cancer progression via negative regulation of SMAD4 |
https://doi.org/10.18632/oncotarget.4124
Xiang Xia,
Kundong Zhang,
Gang Cen,
Tao Jiang,
Jun Cao,
Kejian Huang,
Chen Huang,
Qian Zhao,
and Zhengjun Qiu
|
21046-21063 |
High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients
High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients |
https://doi.org/10.18632/oncotarget.4222
Yuzo Nagai,
Yoko Yamamoto,
Takaaki Yasuhara,
Keisuke Hata,
Takeshi Nishikawa,
Toshiaki Tanaka,
Junichiro Tanaka,
Tomomichi Kiyomatsu,
Kazushige Kawai,
Hiroaki Nozawa,
Shinsuke Kazama,
Hironori Yamaguchi,
Soichiro Ishihara,
Eiji Sunami,
Takeharu Yamanaka,
Kiyoshi Miyagawa,
and Toshiaki Watanabe
|
21064-21073 |
Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells
Pharmacological inactivation of CHK1 and WEE1 induces mitotic catastrophe in nasopharyngeal carcinoma cells |
https://doi.org/10.18632/oncotarget.4020
Joyce P.Y. Mak,
Wing Yu Man,
Jeremy P.H. Chow,
Hoi Tang Ma,
and Randy Y.C. Poon
|
21074-21084 |
Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells
Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells |
https://doi.org/10.18632/oncotarget.3912
Imayavaramban Lakshmanan,
Parthasarathy Seshacharyulu,
Dhanya Haridas,
Satyanarayana Rachagani,
Suprit Gupta,
Suhasini Joshi,
Chittibabu Guda,
Ying Yan,
Maneesh Jain,
Apar K. Ganti,
Moorthy P. Ponnusamy,
and Surinder K. Batra
|
21085-21099 |
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women
Leptin stimulates migration and invasion and maintains cancer stem-like properties in ovarian cancer cells: an explanation for poor outcomes in obese women |
https://doi.org/10.18632/oncotarget.4228
Sumie Kato,
Lorena Abarzua-Catalan,
César Trigo,
Ana Delpiano,
Cristobal Sanhueza,
Karen García,
Carolina Ibañez,
Katherine Hormazábal,
Daniela Diaz,
Jorge Brañes,
Enrique Castellón,
Erasmo Bravo,
Gareth Owen,
and Mauricio A. Cuello
|
21100-21119 |
By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer
By inhibiting snail signaling and miR-23a-3p, osthole suppresses the EMT-mediated metastatic ability in prostate cancer |
https://doi.org/10.18632/oncotarget.4229
Yu-Ching Wen,
Wei-Jiunn Lee,
Peng Tan,
Shun-Fa Yang,
Michael Hsiao,
Liang-Ming Lee,
and Ming-Hsien Chien
|
21120-21136 |
A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model
A combination of YM-155, a small molecule survivin inhibitor, and IL-2 potently suppresses renal cell carcinoma in murine model |
https://doi.org/10.18632/oncotarget.4121
Kai Guo,
Peng Huang,
Naijin Xu,
Peng Xu,
Haruki Kaku,
Shaobo Zheng,
Abai Xu,
Eiji Matsuura,
Chunxiao Liu,
and Hiromi Kumon
|
21137-21147 |
Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer
Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer |
https://doi.org/10.18632/oncotarget.4125
Peng Wang,
Chao-feng Zhu,
Ming-zhe Ma,
Gang Chen,
Ming Song,
Zhao-lei Zeng,
Wen-hua Lu,
Jing Yang,
Shijun Wen,
Paul J. Chiao,
Yumin Hu,
and Peng Huang
|
21148-21158 |
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199
Bcl-2high mantle cell lymphoma cells are sensitized to acadesine with ABT-199 |
https://doi.org/10.18632/oncotarget.4230
Arnau Montraveta,
Sílvia Xargay-Torrent,
Laia Rosich,
Mònica López-Guerra,
Jocabed Roldán,
Vanina Rodríguez,
Eriong Lee-Vergés,
Mercè de Frías,
Clara Campàs,
Elias Campo,
Gaël Roué,
and Dolors Colomer
|
21159-21172 |
Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells
Ca2+ influx-mediated dilation of the endoplasmic reticulum and c-FLIPL downregulation trigger CDDO-Me-induced apoptosis in breast cancer cells |
https://doi.org/10.18632/oncotarget.4065
Soo Ah Jeong,
In Young Kim,
A Reum Lee,
Mi Jin Yoon,
Hyeseong Cho,
Jong-Soo Lee,
and Kyeong Sook Choi
|
21173-21192 |
Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma
Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma |
https://doi.org/10.18632/oncotarget.4176
Reham Abdel-Wahab,
Samir Shehata,
Manal M. Hassan,
Lianchun Xiao,
Ju-Seog Lee,
Sheree Cheung,
Hoda H. Essa,
Hesham M. Hassabo,
Ahmed S. Shalaby,
Eman Mosad,
Kanwal Raghav,
Asif Rashid,
Robert A. Wolff,
Jeffrey S. Morris,
Hesham M. Amin,
and Ahmed O. Kaseb
|
21193-21207 |
Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2
Metformin combined with aspirin significantly inhibit pancreatic cancer cell growth in vitro and in vivo by suppressing anti-apoptotic proteins Mcl-1 and Bcl-2 |
https://doi.org/10.18632/oncotarget.4126
Wen Yue,
Xi Zheng,
Yong Lin,
Chung S. Yang,
Qing Xu,
Darren Carpizo,
Huarong Huang,
Robert S. DiPaola,
and Xiang-Lin Tan
|
21208-21224 |
TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer
TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer |
https://doi.org/10.18632/oncotarget.4237
Wen-bin Liu,
Fei Han,
Xiao Jiang,
Hong-qiang Chen,
Huan Zhao,
Yong Liu,
Yong-hong Li,
Chuanshu Huang,
Jia Cao,
and Jin-yi Liu
|
21225-21239 |
p53 attenuates AKT signaling by modulating membrane phospholipid composition
p53 attenuates AKT signaling by modulating membrane phospholipid composition |
https://doi.org/10.18632/oncotarget.4067
Natalia Rueda-Rincon,
Katarzyna Bloch,
Rita Derua,
Rajesh Vyas,
Amy Harms,
Thomas Hankemeier,
Niamat Ali Khan,
Jonas Dehairs,
Muralidhararao Bagadi,
Maria Mercedes Binda,
Etienne Waelkens,
Jean-Christophe Marine,
and Johannes V. Swinnen
|
21240-21254 |
Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening
Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening |
https://doi.org/10.18632/oncotarget.4013
Maria A. Theodoraki,
Celso O. Rezende Jr.,
Oraphin Chantarasriwong,
Adriana D. Corben,
Emmanuel A. Theodorakis,
and Mary L. Alpaugh
|
21255-21267 |
Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor
Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor |
https://doi.org/10.18632/oncotarget.4178
Tripti Singh,
Nirzari A. Gupta,
Su Xu,
Ram Prasad,
Sadanandan E. Velu,
and Santosh K. Katiyar
|
21268-21282 |
Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface
Down-regulation of α-L-fucosidase 1 expression confers inferior survival for triple-negative breast cancer patients by modulating the glycosylation status of the tumor cell surface |
https://doi.org/10.18632/oncotarget.4238
Tzu-Chun Cheng,
Shih-Hsin Tu,
Li-Ching Chen,
Ming-Yao Chen,
Wen-Ye Chen,
Yen-Kuang Lin,
Chi-Tang Ho,
Shyr-Yi Lin,
Chih-Hsiung Wu,
and Yuan-Soon Ho
|
21283-21300 |
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells
The peroxisome proliferator activated receptor gamma agonist pioglitazone increases functional expression of the glutamate transporter excitatory amino acid transporter 2 (EAAT2) in human glioblastoma cells |
https://doi.org/10.18632/oncotarget.4019
Jared Ching,
Stephanie Amiridis,
Stanley S. Stylli,
Andrew R. Bjorksten,
Nicole Kountouri,
Thomas Zheng,
Lucy Paradiso,
Rodney B. Luwor,
Andrew P. Morokoff,
Terence J. O’Brien,
and Andrew H. Kaye
|
21301-21314 |
CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis
CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis |
https://doi.org/10.18632/oncotarget.4066
Muhammad Noman Khan,
Bing Wang,
Jing Wei,
Yingqiu Zhang,
Qiang Li,
Xuelin Luan,
Jya-Wei Cheng,
John R. Gordon,
Fang Li,
and Han Liu
|
21315-21327 |
K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis
K-Ras stabilization by estrogen via PKCδ is involved in endometrial tumorigenesis |
https://doi.org/10.18632/oncotarget.4049
Kyoung-Hwa Koo,
Woo-Jeong Jeong,
Yong-Hee Cho,
Jong-Chan Park,
Do Sik Min,
and Kang-Yell Choi
|
21328-21340 |
ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib
ZD6474, a new treatment strategy for human osteosarcoma, and its potential synergistic effect with celecoxib |
https://doi.org/10.18632/oncotarget.4179
Jiani Liu,
Jiangxue Wu,
Ling Zhou,
Changchuan Pan,
Yi Zhou,
Wuying Du,
Jie-min Chen,
Xiaofeng Zhu,
Jingnan Shen,
Shuai Chen,
Ran-yi Liu,
and Wenlin Huang
|
21341-21352 |
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer |
https://doi.org/10.18632/oncotarget.3860
Andrew J. Wilson,
Oluwole Fadare,
Alicia Beeghly-Fadiel,
Deok-Soo Son,
Qi Liu,
Shilin Zhao,
Jeanette Saskowski,
Md. Jashim Uddin,
Cristina Daniel,
Brenda Crews,
Brian D. Lehmann,
Jennifer A. Pietenpol,
Marta A. Crispens,
Lawrence J. Marnett,
and Dineo Khabele
|
21353-21368 |
Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5)
Ataxin-3 like (ATXN3L), a member of the Josephin family of deubiquitinating enzymes, promotes breast cancer proliferation by deubiquitinating Krüppel-like factor 5 (KLF5) |
https://doi.org/10.18632/oncotarget.4128
Fei Ge,
Wenlin Chen,
Junying Qin,
Zhongmei Zhou,
Rong Liu,
Linlin Liu,
Jing Tan,
Tianning Zou,
Hongyuan Li,
Guosheng Ren,
and Ceshi Chen
|
21369-21378 |
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti-prostate cancer activity, and mechanisms of action |
https://doi.org/10.18632/oncotarget.4091
Sukesh Voruganti,
Jiang-Jiang Qin,
Sushanta Sarkar,
Subhasree Nag,
Ismail A. Walbi,
Shu Wang,
Yuqing Zhao,
Wei Wang,
and Ruiwen Zhang
|
21379-21394 |
BEX1 acts as a tumor suppressor in acute myeloid leukemia
BEX1 acts as a tumor suppressor in acute myeloid leukemia |
https://doi.org/10.18632/oncotarget.4095
Oscar Lindblad,
Tianfeng Li,
Xianwei Su,
Jianmin Sun,
Nuzhat N. Kabir,
Fredrik Levander,
Hui Zhao,
Gang Lu,
Lars Rönnstrand,
and Julhash U. Kazi
|
21395-21405 |
PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription
PinX1 serves as a potential prognostic indicator for clear cell renal cell carcinoma and inhibits its invasion and metastasis by suppressing MMP-2 via NF-κB-dependent transcription |
https://doi.org/10.18632/oncotarget.4011
Hai-Long Li,
Li Han,
Hai-Rong Chen,
Fei Meng,
Qing-Hua Liu,
Zhen-Qiang Pan,
Jin Bai,
and Jun-Nian Zheng
|
21406-21420 |
Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target
Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target |
https://doi.org/10.18632/oncotarget.4070
Bashar Zeidan,
Thomas R. Jackson,
Samantha E.T. Larkin,
Ramsey I. Cutress,
Gary R. Coulton,
Margaret Ashton-Key,
Nick Murray,
Graham Packham,
Vassilis Gorgoulis,
Spiros D. Garbis,
and Paul A. Townsend
|
21421-21427 |
Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer
Identification of epidermal growth factor receptor and its inhibitory microRNA141 as novel targets of Krüppel-like factor 8 in breast cancer |
https://doi.org/10.18632/oncotarget.4077
Tianshu Li,
Heng Lu,
Debarati Mukherjee,
Satadru K. Lahiri,
Chao Shen,
Lin Yu,
and Jihe Zhao
|
21428-21442 |
NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells
NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells |
https://doi.org/10.18632/oncotarget.4167
Yi Zhu,
Minmin Shi,
Hao Chen,
Jiangning Gu,
Jiaqiang Zhang,
Baiyong Shen,
Xiaxing Deng,
Junjie Xie,
Xi Zhan,
and Chenghong Peng
|
21443-21451 |
Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium
Rapamycin inhibits Erk1/2-mediated neuronal apoptosis caused by cadmium |
https://doi.org/10.18632/oncotarget.4087
Chong Xu,
Hai Zhang,
Chunxiao Liu,
Yu Zhu,
Xiaoxue Wang,
Wei Gao,
Shile Huang,
and Long Chen
|
21452-21467 |
Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-β2 and Ran GTPase in human glioblastoma cells
Nuclear translocation of fibroblast growth factor-2 (FGF2) is regulated by Karyopherin-β2 and Ran GTPase in human glioblastoma cells |
https://doi.org/10.18632/oncotarget.4097
Feng Wang,
Lijun Yang,
Lin Shi,
Qian Li,
Gengshen Zhang,
Jianliang Wu,
Jun Zheng,
and Baohua Jiao
|
21468-21478 |
MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function
MDM2 mediates p73 ubiquitination: a new molecular mechanism for suppression of p73 function |
https://doi.org/10.18632/oncotarget.4086
Hong Wu,
and Roger P. Leng
|
21479-21492 |
Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic
Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic |
https://doi.org/10.18632/oncotarget.4085
Zhuang Miao,
Lin Wu,
Ming Lu,
Xianzhi Meng,
Bo Gao,
Xin Qiao,
Weihui Zhang,
and Dongbo Xue
|
21493-21506 |
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling
Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling |
https://doi.org/10.18632/oncotarget.4242
Anja Heinemann,
Carleen Cullinane,
Ricardo De Paoli-Iseppi,
James S. Wilmott,
Dilini Gunatilake,
Jason Madore,
Dario Strbenac,
Jean Y. Yang,
Kavitha Gowrishankar,
Jessamy C. Tiffen,
Rab K. Prinjha,
Nicholas Smithers,
Grant A. McArthur,
Peter Hersey,
and Stuart J. Gallagher
|
21507-21521 |
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies
Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies |
https://doi.org/10.18632/oncotarget.3974
Wolfgang Jäger,
Hui Xue,
Tetsutaro Hayashi,
Claudia Janssen,
Shannon Awrey,
Alexander W. Wyatt,
Shawn Anderson,
Igor Moskalev,
Anne Haegert,
Mohammed Alshalalfa,
Nicholas Erho,
Elai Davicioni,
Ladan Fazli,
Estelle Li,
Colin Collins,
Yuzhuo Wang,
and Peter C. Black
|
21522-21532 |
A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity
A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity |
https://doi.org/10.18632/oncotarget.4071
De-Gang Song,
Qunrui Ye,
Mathilde Poussin,
Lin Liu,
Mariangela Figini,
and Daniel J. Powell Jr.
|
21533-21546 |
Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001
Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001 |
https://doi.org/10.18632/oncotarget.4249
Shoucheng Ning,
Thillai Veerapazham Sekar,
Jan Scicinski,
Bryan Oronsky,
Donna M. Peehl,
Susan J. Knox,
and Ramasamy Paulmurugan
|
21547-21556 |
Inhibition of Bcl-xL overcomes polyploidy resistance and leads to apoptotic cell death in acute myeloid leukemia cells
Inhibition of Bcl-xL overcomes polyploidy resistance and leads to apoptotic cell death in acute myeloid leukemia cells |
https://doi.org/10.18632/oncotarget.4306
Weihua Zhou,
Jie Xu,
Elise Gelston,
Xing Wu,
Zhengzhi Zou,
Bin Wang,
Yunxin Zeng,
Hua Wang,
Anwen Liu,
Lingzhi Xu,
and Quentin Liu
|
21557-21571 |
Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells: role of plasma membrane depolarization
Distinct effects of TRAIL on the mitochondrial network in human cancer cells and normal cells: role of plasma membrane depolarization |
https://doi.org/10.18632/oncotarget.4268
Yoshihiro Suzuki-Karasaki,
Kyoko Fujiwara,
Kosuke Saito,
Miki Suzuki-Karasaki,
Toyoko Ochiai,
and Masayoshi Soma
|
21572-21588 |
A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice
A dominant-negative F-box deleted mutant of E3 ubiquitin ligase, β-TrCP1/FWD1, markedly reduces myeloma cell growth and survival in mice |
https://doi.org/10.18632/oncotarget.4120
Ramaswamy Sharma,
Paul J. Williams,
Anjana Gupta,
Brandon McCluskey,
Shylesh Bhaskaran,
Steve Muñoz,
and Babatunde O. Oyajobi
|
21589-21602 |
siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cells
siRNAs with decreased off-target effect facilitate the identification of essential genes in cancer cells |
https://doi.org/10.18632/oncotarget.4269
Chunyan Li,
Zhenzhen Liu,
Fang Yang,
Wensheng Liu,
Di Wang,
Encheng Dong,
Yu Wang,
Chung-I Wu,
and Xuemei Lu
|
21603-21613 |
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients
Effects of TGF-beta signalling inhibition with galunisertib (LY2157299) in hepatocellular carcinoma models and in ex vivo whole tumor tissue samples from patients |
https://doi.org/10.18632/oncotarget.4308
Maria Serova,
Annemilaï Tijeras-Raballand,
Célia Dos Santos,
Miguel Albuquerque,
Valerie Paradis,
Cindy Neuzillet,
Karim A. Benhadji,
Eric Raymond,
Sandrine Faivre,
and Armand de Gramont
|
21614-21627 |
Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft
Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft |
https://doi.org/10.18632/oncotarget.4129
Teruo Inamoto,
Kohei Taniguchi,
Kiyoshi Takahara,
Ayako Iwatsuki,
Tomoaki Takai,
Kazumasa Komura,
Yuki Yoshikawa,
Taizo Uchimoto,
Kenkichi Saito,
Naoki Tanda,
Junko Kouno,
Koichiro Minami,
Hirofumi Uehara,
Hajime Hirano,
Hayahito Nomi,
Satoshi Kiyama,
Yukihiro Akao,
and Haruhito Azuma
|
21628-21635 |
Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib
Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib |
https://doi.org/10.18632/oncotarget.4270
Kazuko Sakai,
Haruhiko Takeda,
Norihiro Nishijima,
Etsuro Orito,
Kouji Joko,
Yasushi Uchida,
Namiki Izumi,
Kazuto Nishio,
and Yukio Osaki
|
21636-21644 |
Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma
Expression of miR-27a-3p is an independent predictive factor for recurrence in clear cell renal cell carcinoma |
https://doi.org/10.18632/oncotarget.4064
Wataru Nakata,
Motohide Uemura,
Mototaka Sato,
Kazutoshi Fujita,
Kentaro Jingushi,
Yuko Ueda,
Kaori Kitae,
Kazutake Tsujikawa,
and Norio Nonomura
|
21645-21654 |
Noncanonical roles of membranous lysyl-tRNA synthetase in transducing cell-substrate signaling for invasive dissemination of colon cancer spheroids in 3D collagen I gels
Noncanonical roles of membranous lysyl-tRNA synthetase in transducing cell-substrate signaling for invasive dissemination of colon cancer spheroids in 3D collagen I gels |
https://doi.org/10.18632/oncotarget.4130
Seo Hee Nam,
Doyeun Kim,
Mi-Sook Lee,
Doohyung Lee,
Tae Kyoung Kwak,
Minkyung Kang,
Jihye Ryu,
Hye-Jin Kim,
Haeng Eun Song,
Jungeun Choi,
Gyu-Ho Lee,
Sang-Yeob Kim,
Song Hwa Park,
Dae Gyu Kim,
Nam Hoon Kwon,
Tai Young Kim,
Jean Paul Thiery,
Sunghoon Kim,
and Jung Weon Lee
|
21655-21674 |
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer |
https://doi.org/10.18632/oncotarget.4328
Nelma Pertega-Gomes,
Jose R. Vizcaino,
Sergio Felisbino,
Anne Y. Warren,
Greg Shaw,
Jonathan Kay,
Hayley Whitaker,
Andy G. Lynch,
Lee Fryer,
David E. Neal,
and Charles E. Massie
|
21675-21684 |
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer
Expression profiling of nuclear receptors in breast cancer identifies TLX as a mediator of growth and invasion in triple-negative breast cancer |
https://doi.org/10.18632/oncotarget.3942
Meng-Lay Lin,
Hetal Patel,
Judit Remenyi,
Christopher R. S. Banerji,
Chun-Fui Lai,
Manikandan Periyasamy,
Ylenia Lombardo,
Claudia Busonero,
Silvia Ottaviani,
Alun Passey,
Philip R. Quinlan,
Colin A. Purdie,
Lee B. Jordan,
Alastair M. Thompson,
Richard S. Finn,
Oscar M. Rueda,
Carlos Caldas,
Jesus Gil,
Charles R. Coombes,
Frances V. Fuller-Pace,
Andrew E. Teschendorff,
Laki Buluwela,
and Simak Ali
|
21685-21703 |
ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer
ERα inhibits epithelial-mesenchymal transition by suppressing Bmi1 in breast cancer |
https://doi.org/10.18632/oncotarget.3966
Xiao-Long Wei,
Xiao-Wei Dou,
Jing-Wen Bai,
Xiang-Rong Luo,
Si-Qi Qiu,
Di-Di Xi,
Wen-He Huang,
Cai-Wen Du,
Kwan Man,
and Guo-Jun Zhang
|
21704-21717 |
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma
Identification of alsterpaullone as a novel small molecule inhibitor to target group 3 medulloblastoma |
https://doi.org/10.18632/oncotarget.4304
Claudia C. Faria,
Sameer Agnihotri,
Stephen C. Mack,
Brian J. Golbourn,
Roberto J. Diaz,
Samantha Olsen,
Melissa Bryant,
Matthew Bebenek,
Xin Wang,
Kelsey C. Bertrand,
Michelle Kushida,
Renee Head,
Ian Clark,
Peter Dirks,
Christian A. Smith,
Michael D. Taylor,
and James T. Rutka
|
21718-21729 |
Identification of novel long non-coding RNAs in triple-negative breast cancer
Identification of novel long non-coding RNAs in triple-negative breast cancer |
https://doi.org/10.18632/oncotarget.4419
Xiaokun Shen,
Bojian Xie,
Zhaosheng Ma,
Wenjie Yu,
Wenmin Wang,
Dong Xu,
Xinqiang Yan,
Beibei Chen,
Longyao Yu,
Jicheng Li,
Xiaobing Chen,
Kan Ding,
and Feilin Cao
|
21730-21739 |
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel
Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel |
https://doi.org/10.18632/oncotarget.3226
Pedram Kharaziha,
Dimitris Chioureas,
Dorothea Rutishauser,
George Baltatzis,
Lena Lennartsson,
Pedro Fonseca,
Alireza Azimi,
Kjell Hultenby,
Roman Zubarev,
Anders Ullén,
Jeffrey Yachnin,
Sten Nilsson,
and Theocharis Panaretakis
|
21740-21754 |
Dyskerin and TERC expression may condition survival in lung cancer patients
Dyskerin and TERC expression may condition survival in lung cancer patients |
https://doi.org/10.18632/oncotarget.4580
Marianna Penzo,
Vienna Ludovini,
Davide Trerè,
Annamaria Siggillino,
Jacopo Vannucci,
Guido Bellezza,
Lucio Crinò,
and Lorenzo Montanaro
|
21755-21760 |